This document describes the formulation and evaluation of mouth dissolving tablets containing the drug mirtazapine. Six formulations of mirtazapine mouth dissolving tablets (F1-F6) were prepared using the wet granulation method. The tablets were evaluated for thickness, hardness, friability, drug content and in vitro drug release. Formulation F6 showed the fastest drug release of 99.16% within 20 seconds and was considered the optimized formulation. Stability studies on F6 showed no significant changes in properties after one month. It was concluded that mouth dissolving tablets of mirtazapine can be successfully formulated to improve bioavailability.
Formulation and Evaluation of Unidirection Bucco- Adhesive Tablet of Sumatrip...Ajay Champaneri
The objective of this research work was to formulate and evaluate PEO WSR
301 bucco-adhesive tablet in combination with Carbopol 934p for controlled
release of Sumatriptan Succinate. To bypass high hepatic first pass metabolism,
unidirection bucco-adhesive tablet is selected dosage form for the experimental
work. Initially preliminary trials were carried out for the selection of excipients
and their relative quantity for incorporation in the dosage form. From the results,
Polyethylene oxide-PEO WSR 301 (mucoadhesive polymer) and Carbopol 934p
(control release) were selected as a suitable excipients for experimentation.
Composition of the mucoadhesive tablet was optimized using 32 full factorial
design where amount of PEO WSR 301 (X1) and amount of Carbopol 934p (X2)
were taken as independent variables and mucoadhesive strength, Drug release
at 6 hour and % swelling index taken as response variables. The formulations of
design batches were characterized for post compression parameters like weight
variation, hardness, thickness, friability, Drug content, swelling index, ex-vivo
Mucoadhesive strength, and surface pH, drug release at 6 hr., ex-vivo residence
time, and curve fitting analysis. The optimized formulation was obtained using
Minitab software based on desirability value. Characterization of optimized
batch was carried out by, ex-vivo permeation study.
ABSTRACT
Hyperglycemia is the technical term for high blood glucose (sugar). It
happens when the body has too little or not enough insulin or when the
body can‘t use insulin properly. The main objective of the present
research work was to develop a bilayer tablet of immediate release
Pioglitazone and controlled release Metformin Hydrochloride, which is
used as an Anti-hyperglycemic agent. Metformin Hydrochloride has
biological half-life nearly about 6 hours, so, an attempt was made in
the direction of preparation and optimization of a combination of
sustained release and immediate release in a single tablet. In controlled
release layer natural gums like xanthum gum, gum trgacanth and guar
gum were used as retarding materials and in immediate release laye
croscarmellose sodium was used as a superdisintegrent to give the faster release of
pioglitazone. The tablets were prepared by wet granulation method and by direct
compression. Granules were evaluated for precompression parameters and the tablets were
evaluated for post compression parameters.
Key Words: Bilayer tablets, Metformin Hydrochloride, pioglitazone, xanthum gum, guar
gum, gum tragacanth and crosscarmellose sodium.
Formulation and Evaluation of Unidirection Bucco- Adhesive Tablet of Sumatrip...Ajay Champaneri
The objective of this research work was to formulate and evaluate PEO WSR
301 bucco-adhesive tablet in combination with Carbopol 934p for controlled
release of Sumatriptan Succinate. To bypass high hepatic first pass metabolism,
unidirection bucco-adhesive tablet is selected dosage form for the experimental
work. Initially preliminary trials were carried out for the selection of excipients
and their relative quantity for incorporation in the dosage form. From the results,
Polyethylene oxide-PEO WSR 301 (mucoadhesive polymer) and Carbopol 934p
(control release) were selected as a suitable excipients for experimentation.
Composition of the mucoadhesive tablet was optimized using 32 full factorial
design where amount of PEO WSR 301 (X1) and amount of Carbopol 934p (X2)
were taken as independent variables and mucoadhesive strength, Drug release
at 6 hour and % swelling index taken as response variables. The formulations of
design batches were characterized for post compression parameters like weight
variation, hardness, thickness, friability, Drug content, swelling index, ex-vivo
Mucoadhesive strength, and surface pH, drug release at 6 hr., ex-vivo residence
time, and curve fitting analysis. The optimized formulation was obtained using
Minitab software based on desirability value. Characterization of optimized
batch was carried out by, ex-vivo permeation study.
ABSTRACT
Hyperglycemia is the technical term for high blood glucose (sugar). It
happens when the body has too little or not enough insulin or when the
body can‘t use insulin properly. The main objective of the present
research work was to develop a bilayer tablet of immediate release
Pioglitazone and controlled release Metformin Hydrochloride, which is
used as an Anti-hyperglycemic agent. Metformin Hydrochloride has
biological half-life nearly about 6 hours, so, an attempt was made in
the direction of preparation and optimization of a combination of
sustained release and immediate release in a single tablet. In controlled
release layer natural gums like xanthum gum, gum trgacanth and guar
gum were used as retarding materials and in immediate release laye
croscarmellose sodium was used as a superdisintegrent to give the faster release of
pioglitazone. The tablets were prepared by wet granulation method and by direct
compression. Granules were evaluated for precompression parameters and the tablets were
evaluated for post compression parameters.
Key Words: Bilayer tablets, Metformin Hydrochloride, pioglitazone, xanthum gum, guar
gum, gum tragacanth and crosscarmellose sodium.
Analytical method Development and Validation for the estimation of Pioglitazo...SriramNagarajan15
This paper describes the analytical method suitable for validation of Pioglitazone hydrochloride by UV Spectrophotometric method. The method utilized UV spectroscopy and the solvent system was consists of 6 N Glacial acetic acid at wave length 270 nm. Validation experiments were performed to demonstrate Specificity, Precision, Linearity, Accuracy, ruggedness. The method was linear over the concentration range of 10-50 µg/ml. The Proposed method was simple, sensitive & reliable with good Precise, Accurate, and Reproducible and rapid for the determination of Pioglitazone. The commercial formulations are estimated without interference. Hence this method can be used for routine determination of Pioglitazone hydrochloride in bulk and their pharmaceutical dosage forms.
Aim: This diploma thesis focused on the study of the influence of two types of high-shear
mixers as well as the effect of poly(meth)acrylate concentrations on the properties of
prepared granules and consequently matrix tablets.
Methods: Caffeine was employed as the model drug and matrix tablets were prepared via
the wet granulation process using two different high-shear mixers either Stephan UMC5 or
Rotolab mixer. Eudragit® NM 30D was used in various concentrations as a wet granulation
agent for time controlled drug release with low permeability and pH independent swelling.
In addition, lactose monohydrate was added as indifferent soluble filler, magnesium
stearate served as the antiadhesive excipient and colloidal silica was added for flowability
improvement. Matrix tablets were evaluated for mass, content and dosage uniformity,
uniformity of dosage units, friability, hardness and dissolution according to Ph. Eur.
Results - Conclusions: All prepared tablets exhibited sustained drug release. The
employment of different mixers for sustained matrix tablets preparation did not
significantly influence the release profile of caffeine (Eudragit® NM concentrations 9-
14%), except when the lower Eudragit® NM concentration (7%) was used for granulation.
Furthermore, Eudragit® NM concentrations (7 – 14% per tablet) did not significantly affect
the release profile of caffeine from matrix tablets, neither in the Stephan UMC5 nor the
Rotolab mixer.
Development and evaluation of a novel twice daily cup core metformin hydrochl...SriramNagarajan19
The study was undertaken with an aim to formulate develop and evaluation of a novel twice daily core cup of Metformin hydrochloride(Antidiabetic drug) tablets using different grades and weight of HPMC polymers as release retarding agent. Granules were evaluated for tests Bulk density, tapped density, Hausner ratio before being punched as tablets. Tablets were tested for weight variation, thickness, hardness and friability as per official procedure. F-2 was found to be 73.90. From the above results and discussion it is concluded that formulation of Cup core tablet of containing Metformin hydrochloride HPMC K 4M & 215: 230 (in mg) can be taken as an ideal or optimized formulation of sustained release tablets for 12hour release as it fulfills all the requirements for sustained release tablet and our study encourages for the further clinical trials on this formulation. The core in cup tablets of Metformin hydrochloride were prepared by wet granulation method, they were evaluated for weight variation, friability, hardness, and thickness for all batches (F1 – F9). No significant difference was observed in the weight of individual tablets from the average weight. The weight variation tests were performed according to the procedure given in the pharmacopoeia. In a weight variation test, pharmacopoeial limit of tablet for percentage deviation is 5%. The average percentage deviation of all tablet formulation was found to be within the pharmacopoeial limit and hence all formulation passed the test for uniformity of weight.
Preparation and evaluation of kollidon sr matrix tablets of tinidazole for co...IJSIT Editor
Amoebiasis is an infection of the large intestine caused by Entamoeba histolytica, and it is mainly
present in the intra-intestinal lumen. The efficient treatment of amoebiasis and other colonic infections could
be achieved by targeting the drug to the colon. Tinidazole is the drug of choice for intestinal amoebiasis and
other colonic infections and the best approach for this drug is to target the drug to the colon which would
make the drug effective with low dose and prevent the potential hazards observed in conventional dose.
Moreover, addition of suitable polymers in the formulation could enhance the drug solubility. The aim of the
present investigation was to formulate matrix formulations using different concentrations of Kollidon SR and
PVP K-30, Eudragit S100 to prevent the premature drug release in the GI tract, the matrix formulations
further taken for compression to test the suitability for targeted drug delivery to the colon. The release
kinetics of the formulations was calculated. All the Matrix, compression coated formulations showed the
desired physicochemical properties as per the official limits. Based on the drug release study in pH 1.2 (0.1N
HCl), Phosphate buffer pH 6.8 and the results showed that among the 9 formulations FE2 and FL3 showed
good dissolution profile to control the drug release respectively.
ABSTRACT
Overactive bladder (OAB) is a prevalent condition which has an adverse effect on quality of life. The presence
of urgency incontinence confers significant morbidity above and beyond that of OAB sufferers who are
continent. The primary treatment for OAB and urgency incontinence is a combination of behavioral measures
and antimuscarinic drug therapy. The ideal antimuscarinic agent should effectively relieve the symptoms of
OAB, with the minimum of side effects; it should be available as a once-daily sustained release formulation
and in dosage strength that allows easy dose titration for the majority of sufferers. Solifenacin succinate was
launched in 2005 and has been shown in both short and long term clinical trials to fulfill these requirements.
Solifenacin is a competitive M3 receptor antagonist with a long half-life (45-68 hours). It is available in two
dosage strengths namely a 5 or 10 mg once-daily tablet. The efficacy and tolerability of solifenacin for the
treatment of all symptoms of OAB has been evaluated in a number of large, placebo controlled, randomized
trials. Long-term safety, efficacy, tolerability and persistence with treatment have been established in an open
label 40 week continuation study.
KEYWORDS
Solifenacin, Urinary incontinence, Overactive bladder and Wet granulation method.
Analytical method Development and Validation for the estimation of Pioglitazo...SriramNagarajan15
This paper describes the analytical method suitable for validation of Pioglitazone hydrochloride by UV Spectrophotometric method. The method utilized UV spectroscopy and the solvent system was consists of 6 N Glacial acetic acid at wave length 270 nm. Validation experiments were performed to demonstrate Specificity, Precision, Linearity, Accuracy, ruggedness. The method was linear over the concentration range of 10-50 µg/ml. The Proposed method was simple, sensitive & reliable with good Precise, Accurate, and Reproducible and rapid for the determination of Pioglitazone. The commercial formulations are estimated without interference. Hence this method can be used for routine determination of Pioglitazone hydrochloride in bulk and their pharmaceutical dosage forms.
Aim: This diploma thesis focused on the study of the influence of two types of high-shear
mixers as well as the effect of poly(meth)acrylate concentrations on the properties of
prepared granules and consequently matrix tablets.
Methods: Caffeine was employed as the model drug and matrix tablets were prepared via
the wet granulation process using two different high-shear mixers either Stephan UMC5 or
Rotolab mixer. Eudragit® NM 30D was used in various concentrations as a wet granulation
agent for time controlled drug release with low permeability and pH independent swelling.
In addition, lactose monohydrate was added as indifferent soluble filler, magnesium
stearate served as the antiadhesive excipient and colloidal silica was added for flowability
improvement. Matrix tablets were evaluated for mass, content and dosage uniformity,
uniformity of dosage units, friability, hardness and dissolution according to Ph. Eur.
Results - Conclusions: All prepared tablets exhibited sustained drug release. The
employment of different mixers for sustained matrix tablets preparation did not
significantly influence the release profile of caffeine (Eudragit® NM concentrations 9-
14%), except when the lower Eudragit® NM concentration (7%) was used for granulation.
Furthermore, Eudragit® NM concentrations (7 – 14% per tablet) did not significantly affect
the release profile of caffeine from matrix tablets, neither in the Stephan UMC5 nor the
Rotolab mixer.
Development and evaluation of a novel twice daily cup core metformin hydrochl...SriramNagarajan19
The study was undertaken with an aim to formulate develop and evaluation of a novel twice daily core cup of Metformin hydrochloride(Antidiabetic drug) tablets using different grades and weight of HPMC polymers as release retarding agent. Granules were evaluated for tests Bulk density, tapped density, Hausner ratio before being punched as tablets. Tablets were tested for weight variation, thickness, hardness and friability as per official procedure. F-2 was found to be 73.90. From the above results and discussion it is concluded that formulation of Cup core tablet of containing Metformin hydrochloride HPMC K 4M & 215: 230 (in mg) can be taken as an ideal or optimized formulation of sustained release tablets for 12hour release as it fulfills all the requirements for sustained release tablet and our study encourages for the further clinical trials on this formulation. The core in cup tablets of Metformin hydrochloride were prepared by wet granulation method, they were evaluated for weight variation, friability, hardness, and thickness for all batches (F1 – F9). No significant difference was observed in the weight of individual tablets from the average weight. The weight variation tests were performed according to the procedure given in the pharmacopoeia. In a weight variation test, pharmacopoeial limit of tablet for percentage deviation is 5%. The average percentage deviation of all tablet formulation was found to be within the pharmacopoeial limit and hence all formulation passed the test for uniformity of weight.
Preparation and evaluation of kollidon sr matrix tablets of tinidazole for co...IJSIT Editor
Amoebiasis is an infection of the large intestine caused by Entamoeba histolytica, and it is mainly
present in the intra-intestinal lumen. The efficient treatment of amoebiasis and other colonic infections could
be achieved by targeting the drug to the colon. Tinidazole is the drug of choice for intestinal amoebiasis and
other colonic infections and the best approach for this drug is to target the drug to the colon which would
make the drug effective with low dose and prevent the potential hazards observed in conventional dose.
Moreover, addition of suitable polymers in the formulation could enhance the drug solubility. The aim of the
present investigation was to formulate matrix formulations using different concentrations of Kollidon SR and
PVP K-30, Eudragit S100 to prevent the premature drug release in the GI tract, the matrix formulations
further taken for compression to test the suitability for targeted drug delivery to the colon. The release
kinetics of the formulations was calculated. All the Matrix, compression coated formulations showed the
desired physicochemical properties as per the official limits. Based on the drug release study in pH 1.2 (0.1N
HCl), Phosphate buffer pH 6.8 and the results showed that among the 9 formulations FE2 and FL3 showed
good dissolution profile to control the drug release respectively.
ABSTRACT
Overactive bladder (OAB) is a prevalent condition which has an adverse effect on quality of life. The presence
of urgency incontinence confers significant morbidity above and beyond that of OAB sufferers who are
continent. The primary treatment for OAB and urgency incontinence is a combination of behavioral measures
and antimuscarinic drug therapy. The ideal antimuscarinic agent should effectively relieve the symptoms of
OAB, with the minimum of side effects; it should be available as a once-daily sustained release formulation
and in dosage strength that allows easy dose titration for the majority of sufferers. Solifenacin succinate was
launched in 2005 and has been shown in both short and long term clinical trials to fulfill these requirements.
Solifenacin is a competitive M3 receptor antagonist with a long half-life (45-68 hours). It is available in two
dosage strengths namely a 5 or 10 mg once-daily tablet. The efficacy and tolerability of solifenacin for the
treatment of all symptoms of OAB has been evaluated in a number of large, placebo controlled, randomized
trials. Long-term safety, efficacy, tolerability and persistence with treatment have been established in an open
label 40 week continuation study.
KEYWORDS
Solifenacin, Urinary incontinence, Overactive bladder and Wet granulation method.
Formulation development and invitro evaluation of lamotrigine fast dissolving...SriramNagarajan19
The present study was to formulate and evaluate oral fast dissolving Oral tablet containing Lamotrigine. Present study reveals that all the nine formulated tablet showed satisfactory tablet parameters. It can be concluded that, Oral fast dissolving tablet -containing Lamotrigine can be prepared by direct compression method. 10% CCS (FV) tablet exhibited required disintegration time and dissolution time. The drug release was about 98.7 % in 15min. The accelerated stability studies of the optimized F5 formulation indicates that the formulated oral fast dissolving tablet were unaffected after 3 months storage under accelerated conditions as there were no signs of visually distinguishable changes in appearance, disintegration time and cumulative percentage of drug release. From the present investigation it can be concluded that oral fast dissolving tablet formulation can be a potential novel drug dosage form for pediatric, geriatric and also for general population.
In the present study an attempt will be made to design oral disintegrating tablets of Sumatriptan succinate (anti migraine) by using treated agar and Croscarmellose sodium as a superdisintigrants with a view to provide a convenient means of administration to those patients suffering from difficulties in swallowing such as pediatric and geriatric patients and uncooperative mentally ill patients.
Design and in vitro evaluation of bilayer tablets of Tramadol hydrochloride f...ijperSS
ABSTRACT
The aim of the present work was to design bilayer tablet of Tramadol hydrochloride for biphasic release and its in vitro evaluation. Bilayer tablets comprises of two layers, i.e., immediate release and sustained release layer. The immediate release layer comprised of various superdisintegrants and the sustained release layer comprised HPMC K4M, HPMC K15M, and HPMC K100M as the release retarding polymers. The bilayer tablets were prepared by direct compression method. The seven different formulations (F1-F7) were evaluated for pre- and post-compression parameters. In vitro dissolution studies were carried out for the optimized formulation (F6). It has found that the release of drug from the sustained release layer by 99.5% in 12 h. FT-IR studies revealed that there was no interaction between the drug and polymers used in the study. The release of Tramadol hydrochloride was found to follow a pattern of Korsmeyer-Peppas, with Quasi-Fickian diffusion. Accelerated stability studies were carried out on the prepared tablets in accordance with ICH guidelines. There were no changes observed in physicochemical properties and drug release pattern of tablets. Biphasic drug release pattern was successfully achieved through the formulation of bilayer tablets in this study.
Key words: Tramadol hydrochloride, bilayer tablet, direct compression, carmellose sodium, cross povidone, HPMC K4M.
Design and Development of Immediate and Sustained Release Tablets of Vildagl...Santosh Adhikari
Design and Development of Immediate and Sustained Release Tablets of
Vildagliptin.
Priyanka Shrestha1
*, Shiva Kumar Bhandari1
, SM Ashraful Islam1
, Md Selim Reza2
,
and Santosh Adhikari
3.
1
Department of Pharmacy, University of Asia Pacific, Dhanmondi, Dhaka-1209, Bangladesh
2
Department of Pharmaceutical Technology, University of Dhaka, Dhaka-1000, Bangladesh
3
Department of Pharmacy, Rajiv Gandhi University of Health Sciences, Banglore-560 041, Karnataka, India.
E2 design and development of immediate and sustained release tablets of vilda...Priyanka Shrestha
Research Journal of Pharmaceutical, Biological and Chemical Sciences
Design and Development of Immediate and Sustained Release Tablets of Vildagliptin.
Formulation and Evaluation of Gliclazide Immediate Release and Metformin Sust...ijtsrd
The aim of the present work is to formulate and evaluate a bilayer tablet BT of Metformin HCl as Sustained release and Gliclazide as Immediate release IR . The polymer used in sustained release is HMPC K100M and the super disintegrant used in immediate release in proportion of Gum Karaya and Croscarmellose sodium by Direct compression method. The Preformulation studied, Bulk density, Tapped density, Housner’s ratio, Carr’s index, Angle of repose and UV of Metformin HCl and Gliclazide is performed. In this study, a bilayer tablet containing gliclazide in IRL and metformin in SRL was made using the direct compression method, with the goal of making the formulations IRL as small as possible. Will release gliclazide as soon as possible to combat postprandial hyperglycaemic level, followed by steady state plasma glucose management by Metformin with a long term release. The hardness of the different formulations ranged from 7.5 8.5 kg cm. All the formulations exhibited less than 1 friability. The drug content analysis of Metformin and Gliclazide in all formulations was found within the I P limits ±5 which indicate that the drug was uniformly distributed in the tablets. The in vitro dissolution study was performed for layer I Metformin up to 12 hrs after every 1hour intervals and for layer II Gliclazide up to 40 min after every 5 min interval . The bilayer tablet contributing initial loading dose and dissolves rapidly, the remainder of the drug in the extended release was constant rate till the end of the dissolution process. The DSC and I.R spectra proved that there was no interaction between the polymer excipients and Metformin, Gliclazide. The stability study of Formulation F4 showed after three months that there was no degradation and the drug was stable under accelerated and real time stability conditions. Gajanan Ramasane | Sujit Kakade | Ashok Bhosale "Formulation and Evaluation of Gliclazide Immediate Release and Metformin Sustain Release Bilayer Tablet" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-5 , August 2022, URL: https://www.ijtsrd.com/papers/ijtsrd50372.pdf Paper URL: https://www.ijtsrd.com/humanities-and-the-arts/education/50372/formulation-and-evaluation-of-gliclazide-immediate-release-and-metformin-sustain-release-bilayer-tablet/gajanan-ramasane
Formulation of an anti-inflammatory drug as fast dissolving tabletsIOSR Journals
The demand for mouth dissolving tablets has been growing during the last decade especially for elderly and children who have difficulties in swallowing. Ketorolac tromethamine is an effective anti-inflammatory agent that has been extensively used for the prevention of pain and inflammation associated with a wide variety of reasons. This study was aimed to form Ketorolac tromethamine mouth dissolving tablets by direct compression using superdisintegratants as crospovidone (CP) ,crosscarmellose sodium (CCS), and sodium starch glycolate (SSG) at concentrations of 3%, 6%, 9%, and 12%. The physical mixtures of the drug and the used excipients were evaluated for their micromeretric properties such as angle of repose, particle size, Hausner's ratio and % compressibility. Also, FTIR spectroscopy and DSC calorimetry were performed to indicate any possible interaction between the drug with the used excipients.All the prepared tablets were evaluated for their weight variation, thickness, hardness, wetting time, and disintegration time. Also in-vitro release study was done for all the prepared tablets using distilled deionized water as dissolution medium at 37.5± 0.5 c˚. Based on in-vitro release study and stability studies, G5 (contained 3% CCS) was found to be the promising formulae and subjected to further studies.
The objective of this research is to obtain sustained release of Phenylephrine hydrochloride. In this research work combination of natural and synthetic gums were used in different ratio to get sustain release different gas generating agents were used to float the tablet. Prepared powder blend is subjected to pre formulation studies. Then prepared tablet were evaluated for different evaluation tests. Finally dissolution data was subjected to various release kinetic models to understand release mechanism of drug. Sujit Ubale | Tejasvee Shinde | Adnan Shaikh "Phenhylephrine Hydrocloride Gastro Retentive Floating Matrix Tablets: Design and in Vitro Evaluation" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-6 , October 2019, URL: https://www.ijtsrd.com/papers/ijtsrd29144.pdf Paper URL: https://www.ijtsrd.com/pharmacy/pharmaceutics/29144/phenhylephrine-hydrocloride-gastro-retentive-floating-matrix-tablets-design-and-in-vitro-evaluation/sujit-ubale
Similar to Formulation and Evaluation of Mouth Dissolving Tablets in Mirtazapine (20)
Formulation, characterization and Evaluation of Transdermal Film Containing N...SriramNagarajan15
Transdermal drug delivery system has numerous advantages over the more traditional drug delivery systems. This includes high bioavailability, steady drug plasma concentration, absence of first pass hepatic metabolism effect. Transdermal film is an adhesive film that has a coating of a drug that is placed on the skin to deliver a specific dose of the drug into the bloodstream over a period. The aim of present study an attempt was made to design the transdermal drug delivery system of naproxen with Ethyl Cellulose polymer in various concentrations. Transdermal films were prepared by solvent casting method by using Dibutylpthalate as plasticizer. The prepared films were characterized in physical appearance, thickness, drug content, weightvaration, Folding endurance, percentage moisture uptake and in-vitro release study.
Traditional Kashmiri Recipe “Shangri-Kahwa” as a Stimulant Drink and Effectiv...SriramNagarajan15
The popular recipe “Shangri-kahwa” is an age old home remedy for respiratory and various other problems in almost whole of Kashmir. It is prepared from important spices like liquorice, clove, cinnamon, and cardamom, which have documented health benefits. Information about its use and method of preparation was obtained from group discussions held in some villages of Baramullah district of Jammu and Kashmir. People in these villages believe that Shangri-kahwa is cost effective, delicious, made from easily available ingredients and can be prepared easily at home. Being residents of this area, the authors are aware of the popularity of this magical drink used as a first line of treatment for various ailments at home, particularly during cold days. This recipe is extremely famous in these villages both as a refreshing and stimulant drink, as well as believed to be highly efficacious in respiratory illnesses. It is cost effective and highly palatable. The ingredients of Shangri-kahwa are being used extensively in Unani system of medicine and Ayurveda for almost same indications as the recipe is used. This study was carried out to highlight the effectiveness and focus the attention of the researchers towards this attractive and effective dosage form used as home remedy in Kashmir.
Antibacterial activity on leaf extracts of Syzgium jambalonamSriramNagarajan15
The purpose of this investigation was to extract the bioactive agents from the Methanol, Acetone extracts were examined for their activities against pathogenic microorganism (Proteus vulgaris, Staphyloccus aureus, Bacillus subtilis and E.coli). The most of the incidence of infections caused by pathogenic microorganism in our routine life and the importance of using novel synergistic drug has become important. In the present study enhanced inhibitory effects were achieved by employing solvent extracts of Syzgium jambalonam. These MIC were compared with well known antibacterial plant of Neem extract (Biological source-Azadirachta indica, Family-Meliaceae).
Bilayer tablet is new era for the successful development of controlled release formulation along with various features to provide a way of successful drug delivery system. Bi-layer tablets developing a combination of two or more Active Pharmaceutical Ingredients (API) in a single dosage form (bilayer tablet) has increased in the pharmaceutical industry, promoting patient convenience and compliance. For a variety of reasons: patent extension, therapeutic, marketing to name a few. To reduce capital investment, quite often existing but modified tablet presses are used to develop and produce such tablets. This article explains why the development and production of quality bi-layer tablets needs to be carried out on purpose-built tablet presses to overcome common bi-layer problems, such as layer-separation, insufficient hardness, inaccurate individual layer weight control, cross-contamination between the layers, reduced yield, etc. Using a modified tablet press may therefore not be your best approach to producing bilayer tablet under GMP-condition. Especially when in addition high production output is required.
Spectrophotometric Estimation of Rosuvastatin Calcium in Bulk and Pharmaceuti...SriramNagarajan15
Rosuvastatin calcium of the class statins is used for primary hyperlipidemias. It is a selective and competitive inhibitor of HMG-CoA reductase. In the present work, simple, sensitive and economic spectrophotometric method has been developed for quantitative determination of Rosuvastatin calcium. In the present spectrophotometric method Rosuvastatin calcium was dissolved in double distilled water. It exhibited an absorption maximum at 241 nm and obeyed Beer’s law in the concentration range of 5-25g/ml. The results of analysis have been validated and found to be sensitive, precise and accurate for quantitative determination of Rosuvastatin calcium in bulk drug and pharmaceutical formulations.
Analytical method development and its application to extractive spectrophotom...SriramNagarajan15
The reagent was synthesized and characterization was carried out by FTIR, NMR, elemental analysis as well as Mass spectrometry. The synthesized reagent was then applied for the development of the analytical method for the extractive spectrophotometric determination of cobalt (II). Cobalt metal forms pale yellow coloured complex, which can be extracted in chloroform at pH 9.4 having absorption maxima at 415 nm. Beer’s law is obeyed in the concentration range 1-8.00 μg. The molar absorptivity and Sandell’s Sensitivity of the extracted species are 7.1724 X 103 Lit mol-1 cm-2 and 8.2165 X 10-3μg cm-2 respectively. The developed method is highly sensitive, selective, simple, rapid, accurate, and has been satisfactorily applied for the determination of cobalt in the synthetic mixtures, pharmaceutical samples, and alloys.
Analytical Method Development and Validation of Dutasteride and Tamsulosin Hc...SriramNagarajan15
A simple,specific, sensitive,precise and reproducible Reverse Phase High Performance liquid Chromatography method has been developed for simultaneous estimation of Dutasteride and Tamsulosin Hcl. Dutasteride and Tamsulosin is Anti-hyperplasia and Anti-hypertensive drug.The determinationwas carried out byusingsymmetryC-18columnwith Methanol:0.1M Monobasic potassiumdihydrogenphosphate buffer(75:25) Adjusted the pH to 2.5 with Ortho phosporic acid as the mobile phase and with the detection wavelength of274 nmrespectively.The flow rate is 0.7 ml/min.TheRetentiontime of Dutasteride,Tamsulosin Hcl was 2.218 minand 6.599 min respectively.Linearityforthe Dutasteride and Tamsulosin Hcl were found inthe rangeof 25-75µgmand 20-60µgm respectively.The limitof quantificationforbothdrugs wasfound to be30,24µg respectively.The recoveries of Tamsulosin and Dutasteride were found to be inthe range of 99.81-99.90 %and98.00-102.00%, respectively. The proposed method was validated suitably and canbeused for routine analysis. The degradation studies indicated Dutasteride and Tamsulosin Hcl to besusceptible to neutralhydrolysis, while Dutasteride and Tamsulosin Hcl showed degradation inacid, H2O2,photolytic and inpresenceof UV radiation.The degradation productsof Dutasteride andTamsulosin Hcl inacidic and photolytic conditions were well resolved from the pure drug with significant differences in the irretention time values. This method can be successfully employed forsimultaneous quantitative analysis of Dutasteride and Tamsulosin Hcl in formulations.
Synthesis and Pharmacological evaluation of new Benzoxozole DerivativesSriramNagarajan15
Benzoxazoles1 are usually prepared by heating 2-Aminophenol with formic acids in the presence of Boric acid under reflux. Condensation of these two substances under milder conditions. Being a heterocyclic compound, benzoxazole finds use in research as a starting material for the synthesis of larger, usually bioactive structures. It is found within the chemical structures of pharmaceutical drugs such as flunoxaprofen. Benzoxazole derivatives are provided a protection against noxious UV radiation.Benzoxazole derivatives are also used in cosmotic compositions, such as for examples mainly cinnamic acid, 4-aminobenzoic acid.Benzoxazole derivatives are also used in the optical brighteners.These derivatives are used as Anticonvulsant and Neurotoxicity2 , Anti-inflammatory agents3, “Antibacterial activity”4, Cholesteryl ester transfer Protein inhibitors5, Antimicrobial activity6,7, Antifungal activity’8, Cyclooxygenase inhibitors9, hair treatment products and also used as a skin protectants.
Evaluate the Disinfectant Activity of Some Commercial Preparations by Rideal ...SriramNagarajan15
The aim of this study was to evaluate and compare practically achieved disinfection efficacy of some locally available disinfectants on surfaces and infectious microbiological hospital waste. Three disinfectants were tested at concentrations recommended by manufacturers on rough and smooth surfaces that were contaminated experimentally by locally circulating isolates of methicillin-resistant Staphylococcus aureus, multi drug-resistant Acinetobacter baumannii, Klebsiella pneumoniae, Enterobacter aerogenes, Pseudomonas aeruginosa strains, standard isolate of Salmonella typhi and Candida albicans. Reduction in microbial counts before and after surface disinfection was expressed as log reduction. A very heavy microbial waste load was simulated by immersing culture plates with heavy microbial growth in disinfectants. Daily, a sample of disinfectant was taken and subjected to Rideal-walker test.
Synthesis, Characterization and Biological evaluation of substituted Pyrazole...SriramNagarajan15
The work presented in this article consists of synthesis, characterization and biological evaluation of substituted pyrazole derivatives. Pyrazole derivatives have been shown to have wide variety of pharmacological activities like antimicrobial, antiviral, antihistaminic, antitumor, antipyretic, anti-inflammatory, antidepressant and anticonvulsant. As combination of biologically active moieties into one molecule and synthesis of totally newer moieties have been the methods of research, we present here synthesis of some novel pyrazole derivatives incorporating various biologically active aryl/aryloxy acid derivatives such as ibuprofen, diclofenac, aceclofenac as well as potent antibacterial quinolones, norfloxacin and ciprofloxacin. All the compounds synthesized were evaluated for their antimicrobial activity.
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...SriramNagarajan15
A simple, fast and reliable Spectrophotometric method was developed for determination of Pioglitazone hydrochloride in bulk and Pharmaceutical formulation. Spectrophotometrically, Pioglitazone hydrochloride was determined by measuring the maximum absorption at 270nm. Analytical Calibration curves were linear within a concentration range from 10 to 50µg/ml. The developed method was applied to directly and easily to the analysis of the pharmaceutical tablet preparations. % R.S.D was found to be 0.51 for piosis 30 mg Tablet. The %R.S.D values for all method validation parameters were found within 2% for the developed method. The method was completely validated. The results showed that this method can be used for rapid determination of Pioglitazone hydrochloride in bulk and Pharmaceutical tablet formulation with linearity, precision, accuracy specificity.
Synthesis, characterization of certain new heterocyclic hybrids of pyrazoles ...SriramNagarajan15
The work presented in this article consists of synthesis, characterization and biological evaluation of substituted pyrazole derivatives. Pyrazole derivatives have been shown to have wide variety of pharmacological activities like anti-inflammatory, antidepressant and anticonvulsant. As combination of biologically active moieties into one molecule and synthesis of totally newer moieties have been the methods of research, the present study is an attempt to synthesize some novel pyrazole derivatives, incorporating various biologically active aryl / aryloxy acid derivatives, such as ibuprofen, diclofenac, aceclofenac as well as potent antibacterial quinolones, norfloxacin and ciprofloxacin. All the compounds synthesized were evaluated for their anti-inflammatory (Carrageenan induced paw oedema method) activity. The results obtained were found to be compatible with standard literature and standard drug employed. Hence, the obtained derivatives can be subjected to further clinical studies to optimize their clinical efficacy.
Lead toxicity due to paint and other industrial sources and contradiction in ...SriramNagarajan15
Lead is one of the oldest known and most widely studied occupational and environmental toxins. Despite intensive study, there is still vigorous debate about the toxic effects of lead, both from low-level exposure in the general population owing to environmental pollution and historic use of lead in paint and plumbing and from exposure in the occupational setting. The majority of industries historically associated with high lead exposure have made dramatic advances in their control of occupational exposure. However, cases of unacceptably high exposure and even of frank lead poisoning are still seen, predominantly in the demolition and tank cleaning industries. Nevertheless, in most industries blood lead levels have declined below levels at which signs or symptoms are seen and the current focus of attention is on the subclinical effects of exposure. The significance of some of these effects for the overt health of the workers is often the subject of debate. Inevitably there is pressure to reduce lead exposure in the general population and in working environments, but any legislation must be based on a genuine scientific evaluation of the available evidences. We will discuss in this article about the various Mechanism of actions due to toxicity of the lead.
Synthesis, antiviral and cytotoxicity activities of N-Sulphonamidomethyl benz...SriramNagarajan15
A series of novel N-sulphonamido methyl benztriazole derivatives had been synthesized by combining benztriazole, formaldehyde and sulphonamides. Structure of synthesized compounds was elucidated by spectral analysis. Synthesized compounds were evaluated for in-vitro antiviral activity against HIV, HSV and Vaccinia viruses in cell culture. N-Sulphonamido methyl benzotriazole (BT-SN) inhibits Herpes Simplex Virus (HSV) -2 and Vaccinia virus at 34 µg/ml, respectively. HSV-1 at the concentration of 45 µg/ml. The minimum cytotoxic concentration was found to be more than 100µg/ml. So these compounds are suitable for designing newer derivatives and molecular modifications in them may help in optimizing antiviral activity.
Development and validation of HPLC method for the estimation of Escitalopram ...SriramNagarajan15
A simple, specific, robust, accurate and precise isocratic HPLC method has been developed and subsequently validated for simultaneous determination of escitalopram (ESP) in pharmaceutical dosage forms. Kromosil (250x4.6)mm 5µ with flow rate of 1ml/ min by using JASCO PU-1580 and UV/VIS JASCO UV-1570 at 238 nm. The separation was carried out using a mobile phase consisting of acetonitrile, methanol and 5mM ammonium acetate buffer (pH 3.0) in the ratio 30:20:50 respectively. The retention time for escitaloparm was found to be 5.36 minutes respectively. The correlation coefficient was found to be 0.9997 (ESP). The mean percentage recovery was found to be 101.86 respectively. The % estimation of the drugs was found near to 100 % representing the accuracy in the method. The proposed method was also validated and applied for the analysis of drugs in tablet formulation.
In-vivo analgesic, anti-inflammatory and central nervous system - locomotor a...SriramNagarajan15
Two homologous series of 1, 2-disubstituted benzimidazoles carrying isoindolines (6a-n) were synthesized by mannich type reaction of 2-alkyl benzimidazolyl isoindoline-1,3-dione (4a-b) with different substituted aromatic primary amines (5a-g) using formaldehyde in acid as a condensing agent. The pthalic anhydride (1) and amino acids -glycine, alanine (2a-b) fused at 180° c to give 2-(1, 3-dioxoisoindolin-2-yl) carboxylic acids (3a-b). These acids undergo cyclization with 1, 2 diaminobenzene yield (4a-b). The structures of the synthesized isoindolines were confirmed by spectral analysis. The synthesized benzimidazolyl isoindoline were screened for their in-vivo antinociceptive activities. Most of the synthesized isoindolines exhibited significant analgesic and anti-inflammatory activities. Among this isoindolines 6c, 6d, 6e, 6f, 6l, 6k, 6m, 6n were showed appreciable antinociceptive potency. The isoindolines (4a-b) and (6a-n) were screened for their in-vivo central nervous system locomotor activities. Among these tested isoindolines 4a, 4b, 6a, 6b, 6e, 6f were only shows elevated central nervous system depressant potency.
Method Development and Validation of Naftopidil by Reverse Phase-HPLC in Bulk...SriramNagarajan15
A new simple, accurate, rapid and precise isocratic High performance liquid chromatographic (HPLC) method was developed and validated for the determination of Etomidate (ETO) injection. The Method employs Waters HPLC system on Develosil –ods-UG column (300 x 3.9 mm x 5µm) and flow rate of 1.5 mL/min with a load of 20 µL. Acetonitrile and Phosphate buffer was used as mobile phase in the composition of 40:60. The Detection was carried out at 254 nm. Linearity ranges for Etomidate was 40-240 µg/ml respectively. Retention Time of Etomidate was found to be 12.061 minutes respectively. Percent recovery study values of Etomidate were found to be within 98-102 %. This newly developed method was successfully utilized for the Quantitative estimation of Etomidate in injectables. This method was validated for accuracy, precision, linearity and Robustness as per ICH guidelines.
Method Development and Validation of Clopidogrel Bisulphate by Reverse Phase-...SriramNagarajan15
A new, simple sensitive, rapid, accurate and precise RP-HPLC method was developed for the estimation of Clopidogrel bisulphate in bulk drug and pharmaceutical formulation. Clopidogrel bisulphate was chromatographed on a reverse phase C18column (150 mm x 4.5 mm, i.d 5μm) in a mobile phase consisting of acetonitrile and phosphate buffer (pH: 3.0) in the ratio of 60:40 % v/v. The mobile phase was pumped at a flow rate of 1 ml/min with detection at 224 nm. The detector response was linear in the concentration of 50-150 μg /ml. The limit of detection and limit of quantitation was found to be 1.3 and 4.2 µg/ml, respectively. The intra and inter day variation was found to be less than 2%. The mean recovery of the drug from the solution was 99.79%. The proposed method is simple, fast, accurate, precise and reproducible hence, it can be applied for routine quality control analysis of Clopidogrel bisulphate in bulk drug and pharmaceutical formulation. Key words: Clopidogrel bisulphate, RP-HPLC, Validation, Accuracy, Precision.
RP-HPLC Assay Method Validation for the estimation of new Anti-retroviral dru...SriramNagarajan15
A Reverse phase HPLC method was developed for estimation of the Lamivudine in bulk and tablet formulation by using ODS column (250mm×4.6mm, 5µm) and Acetate buffer: acetonitrile (50:50) as mobile phase, at a flow rate of 1.5ml/min. The detection was carried at the 272nm the retention time of the Lamivudine is 1.850. The developed method was validated for the various parameters as per the ICH guidelines like accuracy precision, linearity and range, Robustnes. Linearity was obtained in the concentration range of 10µg/ml to 50µg/ml with correlation coefficient of 0.999. The accuracy of the method was assessed by recovery studies at three different concentration levels. The percentage recovery of Lamivudine was found to be in the range of 98% -102%. The method was found to be precise as indicated by the repeatability, inter-day, intra-day analysis, showing %RSD less than 2. Key words: RP-HPLC, Lamivudine, Pharmaceutical dosage form.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Formulation and Evaluation of Mouth Dissolving Tablets in Mirtazapine
1. 68
* Corresponding author: D.Anbarasu
E-mail address: srianbu12@gmail.com
IJPAR |Volume 2 | Issue 2 | Apr - Jun- 2013 ISSN: 2320-2831
Available Online at: www.ijpar.com
[Research article]
Formulation And Evaluation Of Mouth Dissolving Tablets In Mirtazapine
*1
Anbarasu D, 1
Nepolean R, 1
Chandramohan K, 1
Anandakumar A, 2
Pitchaipillai M.
1
Thanthai Roever college of Pharmacy, Perambalur,Tamilnadu, India - 621212.
2
E.G.S college of Pharmacy, Nagapattinam, Tamilnadu, India.
ABSTRACT
The present study was undertaken with an aim to development of formulation and evaluation of mouth dissolving
tablets in mirtazapine. Mirtazapine, Gelatin, Cross Caramellose Sodium, Mannitol, aerosil, magnesium stearate,
aspartame, mango flavor and microcrystalline cellulose were used for the preparation of tablets. The tablets were
prepared by wet granulation method and evaluated for tablets thickness, weight variation, tablet hardness, friability,
and in vitro drug release. Formulation F6 can be considered as an ideal or optimized formulation for mouth
dissolving tablets of mirtazapine. It can be concluded that mouth dissolving tablet of mirtazapine. Can be
successfully formulated and improving its bio availability.
Keywords: Mirtazapine, cross caramellose sodium, wet granulation method.
INTRODUCTION
Mouth dissolving tablets as a novel dosage form,
have several characteristics to distinguish them from
the more traditional dosage forms. These tablets in
increased bioavailability compared to traditional
tablets1
. Because of dispersion in saliva while still in
the oral cavity, there can be pregastric absorption
from some formulation in those cases where the drug
dissolving quickly and that the substances are rapidly
absorbed via the blood vessels of the tongue rather
than via the digestive tract1,2
. A middle aged women
undergoing radiation therapy for breast cancer may
be too nauseous to swallow her H2-blocker. Mouth
dissolving/fast dissolving tablets are a perfect fit for
all of these patients2
. It is easy of administration for
the disabled, uncooperative, pediatric, geriatric,
bedridden and mentally ill patients with no water
intake and no patient compliance3.
Mirtazapine is a
tetracyclic antidepressant. It is contra indicated in
patients with hyper sensitivity to drug, co
administration with MAO inhibitors is contra
indicated Mirtazapine and its active metabolite
cytochrome P450 isoenzyme involved are CYP 2 D6
and CYP1 A2and CYP 3A4 the N-desmethyl
metabolite is pharmacologically active4,5
.
MATERIALS AND METHODS
Materials
Mirtazapine, cross caramellose sodium, mannitol,
gelatin, Aerosil, Magnesium stearate, aspartame,
micro crystalline cellulose and mango flavour were
obtained from Cassel Research Laboratories,
Chennai.
2. 69
D.Anbarasu et al / Int. J. of Pharmacy and Analytical Research Vol-2(2) 2013 [68-73]
www.ijpar.com
Methods
Preparations of Mirtazapine mouth
dissolving tablets
Tablets were made by wet granulation method.
Mirtazapine was mixed with the required quantities
of gelatin, cross caramellose sodium, mannitol,
Aerosil, Aspartame and micro crystalline cellulose by
geometric mixing. The powder blends was then
lubricated with magnesium stearate and mango flavor
mixed. Finally, the mixture was compressed on a
rotary tablet machine (Fluidpack Mc-200) using
standard 5mm standard flat-face punches to get
140mg weights of tablets. Composition of all
formulation is given in table –1.
Evaluation of Tablets
Evaluation of powder blend
The powder blends of all formulation were evaluated
for Bulk density6
, Tapped density7
, compressibility
index and angle of repose9
.
Evaluation of tablet properties
The prepared tablets were tasted for weight variation,
Hardness (Monsanto hardness tester), Thickness
(Vernier caliper), friability (Electrolab EF-1W) and
drug content.
Dissolving property
The tablets were placed in a 100 ml beaker
containing distilled water. Dissolving time of
fabricated mouth dissolving tablets of batch F 06 was
less than 20 secs, which complies with the
requirements for disintegration of mouth dissolving
tablets.
In vitro Drug Release Study
The release rate of Mirtazapine mouth dissolving
tablets was determined using USP X 1V type 2
(paddle type) dissolution tester. The dissolution test
was performed in triplicate, using 900ml of 0.1NHCl
at 37±0.5 c at 100 rpm for 3 hours. A 5 ml sample
was withdrawn from the dissolution apparatus at
specified time points and the samples were replaced
with fresh dissolution medium. The samples were
filtered through a 0.45µm membrane filter and
diluted if necessary. Absorbances of these solutions
were measured at 294 nm using UV-visible
spectrophotometer.
RESULTS AND DISCUSSION
The compatibility study was carried out for chemical
characteristics of combination such as drug to
excipients used in the formulation drug excipients
compatibility done. The powder blend of six
formulations (F01 –F06) was evaluated for angle of
repose, bulk density, tapped density, showed the pre-
compressed blend has good flow property.(Table:2)
The physical evaluation parameters and drug content
were also tested for the tablets (Table: 3). The total
weight of each formulation was maintained constant;
the weight variation of the tablets were within the
permissible limits of 7.5%, as specified for tablet
weighing less than 325 mg. weight of the tablet was
fixed at 140mg and the weight variation for every
batch was tested and found within the acceptable
limits. Hardness of the tablet was fixed 3kg/cm2
and
was maintained for all the batches.
Tablet thickness was also used to assess the quality of
tablets. Under uniform conditions of manufacture, the
total weight of tablet and thickness were linearly
related. The thickness of tablet ranged from 2.96 to
3.21 mm and linearly correlated with the weight of
the tablets. Friability test of all the formulations was
found satisfactory showing enough resistance to the
mechanical shock and abrasion. Drug content
uniformity in all formulations was calculated and the
presence of active ingredient ranged from 98.78 –
101.01 % (the amount drug released limits NLT 98.5
– NMT 101%) .5,7
In vitro dissolution studies of all formulations are
depicted in table 5. Formulation F1, F2, F3, F4, F5
and F6 prepared with mirtazapine were done in 0.1
NHCl and the drug release from formulations F6 was
99.16% in 25 min. formulation F6 showed the desired
drug release profile and dissolution for desired period
of time within 30 secs, for this reason it was
considered as best formulation among all the six
formulations. (Figure- 1).
Stability studies of mouth dissolving tablets (F6) were
carried out at 45°c for one month. Evaluation of these
tablets indicates that there was no change in the
weight, thickness, hardness and degreased in the drug
content of the tablets loaded for stability. The
dissolution profile of the stability loaded tablets show
that there was slight change in the release rate, but
the amount of drug released 98.52% was within
3. 70
D.Anbarasu et al / Int. J. of Pharmacy and Analytical Research Vol-2(2) 2013 [68-73]
www.ijpar.com
limits. (NLT 98.5% of NMT 101%). The results as
shown in table 6.
Mouth dissolving tablets of mirtazapine formulation
F6 showed improve its bioavailability and better drug
release in comparison to the other formulation, the
extent of if drug release was found to be 99.16 % at
the desired time 20 secs and drug –excipients
interactions was observed. Hence it was concluded
that formulation F6 can be taken as an ideal or
optimized formulation of mouth dissolving tablets for
20 secs.
Table: 1 Formulation of month dissolving tablet of mirtazapine
Ingredients
(mg/tablet)
F1 F2 F3 F4 F5 F6
Mirtazapine
15 15 15 15 15 15
Gelatin 2 4 4 2 2 2
Cross Caramellose
sodium
2 16 4 16 6 6
Mannitol 20 20 20 20 20 20
Aerosil 2 2 2 2 2 2
Magnesium
Stearate
1 2 2 2 2 2
Aspartame 1 1 1 1 1 1
Mango flavour 4 4 4 4 4 4
Sodium starch
Glycolate
- - - - 4 -
Microcrystalline
cellulose
93 76 88 78 84 88
Table: 2 Physical evaluation
Formulation Angle of repose Bulk density Tapped density
F1 25.89 0.496 0.585
F2 23.75 0.473 0.496
F3 24.34 0.431 0.590
F4 24.89 0.495 0.641
F5 25.65 0.523 0.648
F6 26.09 0.570 0.657
4. 71
D.Anbarasu et al / Int. J. of Pharmacy and Analytical Research Vol-2(2) 2013 [68-73]
www.ijpar.com
Table: 3 Physical evaluation parameters and drug content
Formulation
Weight
variation(mg)
Thickness(mm)
Hardness
(kg/cm2)
Friability(%) Diameter(mm)
Drug
content(%)
F1 139±1.3 3.15 2.1-2.6 0.72 7.21 91.73
F2 141.2±0.6 3.21 2.0-2.5 0.80 7.23 98.64
F3 140.1±0.9 2.96 2.56-2.90 0.67 7.20 98.80
F4 139.3±1.7 3.10 2.7-3.10 0.70 7.19 99.65
F5 140.1±1.3 3.18 2.74-2.95 0.54 7.22 99.48
F6 140.4±1.5 3.21 2.78-3.0 0.51 7.15 99.54
Table: 4 In vitro dissolution studies: cumulative percent drug release of formulation
Sampling
time (min)
F1 F2 F3 F4 F5 F6
5 85.3 87.62 88.60 86.14 86.43 87.04
10 90.05 89.93 91.17 92.32 91.07 92.58
15 98.94 97.54 98.53 98.23 99.14 98.57
20 98.96 99.85 98.04 98.96 99.43 99.85
Table: 5 Invitro dissolution studies: cumulative percent drug release of formulation after storage
for one month at 45° C
Sampling
time(min)
F1 2 F3 F4 F5 F6
5 84.20 85.72 85.05 86.14 85.95 86.42
10 89.45 90.13 91.37 93.82 92.27 93.08
15 97.54 98.21 97.72 98.12 97.65 37.68
20 98.61 99.02 98.86 98.73 98.57 98.65
5. 72
D.Anbarasu et al / Int. J. of Pharmacy and Analytical Research Vol-2(2) 2013 [68-73]
www.ijpar.com
Figure: 1 Cumulative % drug release from Mouth Dissolving Tablets (F1 - F6)
0
20
40
60
80
100
120
0 5 10 15 20
cumulative%Drugrelease
Time (min)
F1
F2
F3
F4
F5
F6
Figure: 2 Cumulative percent drug release of formulation after storage for one month at
45° C (F1 – F6)
0
20
40
60
80
100
120
0 5 10 15 20
cumulative%Drugrelease
Time (min)
F1
F2
F3
F4
F5
F6
ACKNOWLEDGEMENT
Authors are thankful to our Mr.Murugan,
Managing Director, Mr.Nataraj, Production
Manager, Cassel research laboratories, Chennai for
providing the facilities for completion of this work.
REFERENCES
1. Seager, H.,Drug delivery products and the Zydis fast dissolving dosage forms,
J.pharm.Pharmacol,1998,50, page:375-382.
2. Kuchegar, B.S. and Arumugam, V., Fast dissolving tablets, Indian J.pharm,Edu., 2001,35, page:150.
6. 73
D.Anbarasu et al / Int. J. of Pharmacy and Analytical Research Vol-2(2) 2013 [68-73]
www.ijpar.com
3. Chang, R.K.Guo., X., Burnside,B.A., and couch,R.A., Fast dissolving tablets, pharm, Tech., 2000,
24(6), page:52-58.
4. Pharmacists drug hand book – by Joseph T.Dipiro, Spring House corporation S.House, Pennsylvania,
2001, page:353.
5. Martindale – The Complete drug reference, edited by sean C sweetman, pharmaceutical press, London,
2002, page: 299-300.
6. Sanyan, S.N.Dulta, A.K., “Study on granule parameter of paracetamol tablets”. The eastern
pharmacist,1992, 35(Jan), page: 175-177.
7. Corveleyn.S and Remon.J.P., “Formulation and productions of Rapidly disintegrating tablets by
lyophilization using hydrochlorothizide as a model drug”, International journal of pharmaceutics ,152,
1997, page: 215-225.
8. Indian pharmacopoeia, edition 1996, page:52,58,70 to 73.
9. Cooper J, Gunn C-Powder flow and compaction;Tutorial pharmacy, CBS publishers and distributors,
New delhi, 1986, page:317-318.
10. Lachman L, Liberman HA, Kanig JL. The Theory and practice of Industrial Pharmacy, Lea and
Febiger, Philadelphia, 1987, page:317-318.
*******************************